Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis

被引:0
作者
Yulu Qiu
Xiaoke Feng
Chang Liu
Yumeng Shi
Lingxiao Xu
Hanxiao You
Lei Wang
Chengyin Lv
Fang Wang
Wenfeng Tan
机构
[1] The First Affiliated Hospital of Nanjing Medical University,Department of Rheumatology
[2] The First Affiliated Hospital of Nanjing Medical University,Department of Traditional Chinese Medicine
[3] Integrated Traditional Chinese and Western Medicine Institute of Nanjing Medical University,Department of Cardiology
[4] The First Affiliated Hospital of Nanjing Medical University,undefined
来源
Arthritis Research & Therapy | / 26卷
关键词
Dermatomyositis; MDA5; Interstitial lung disease; RP-ILD; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 282 条
[1]  
Jin Q(2023)Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis J Intern Med 293 494-507
[2]  
Fu L(2023)Identification of three different phenotypes in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis patients: implications for prediction of rapidly progressive interstitial lung disease Arthritis Rheumatol 75 609-619
[3]  
Yang H(2020)Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases Neurology 95 e70-e78
[4]  
Chen X(2020)Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model Chest 158 1535-1545
[5]  
Lin S(2022)Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease Clin Exp Rheumatol 40 292-297
[6]  
Huang Z(1975)Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 344-347
[7]  
Xu L(2017)Diagnosis and early management of inflammatory arthritis BMJ 358 117-128
[8]  
You H(2021)Sotagliflozin in patients with diabetes and recent worsening heart failure N Engl J Med 384 2120-2128
[9]  
Wang L(2022)Uses of GFR and albuminuria level in acute and chronic kidney disease N Engl J Med 386 1312-1322
[10]  
Lv C(2021)Glycemic index, glycemic load, and cardiovascular disease and mortality N Engl J Med 384 359-362